Phelan-McDermid Syndrome

We are conducting studies to characterize clinical and neurophysiological features associated with Phelan-McDermid Syndrome (PMS). In our PMS studies, individuals will participate in a neurological evaluation, tests of motor abilities, tests of cognitive abilities, and electroencephalography (EEG) testing.

Phelan-McDermid Syndrome Studies

Our PMS study is open to participants with deletions or mutations of the SHANK3 gene who are between ages 2 and 55 years old.